Home/Filings/4/0001213900-22-033623
4//SEC Filing

Erfanian Hamid 4

Accession 0001213900-22-033623

CIK 0000316253other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:31 PM ET

Size

6.9 KB

Accession

0001213900-22-033623

Insider Transaction Report

Form 4
Period: 2022-06-15
Erfanian Hamid
Chief Executive Officer
Transactions
  • Purchase

    Common Stock, $0.01 Par Value

    2022-06-15$2.19/sh+4,600$10,074274,600 total
  • Award

    Stock Option (to acquire Common Stock)

    2021-11-08+700,000700,000 total
    Exercise: $3.39From: 2022-11-08Exp: 2026-11-08Common Stock (700,000 underlying)
Footnotes (1)
  • [F1]The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.

Documents

1 file

Issuer

ENZO BIOCHEM INC

CIK 0000316253

Entity typeother

Related Parties

1
  • filerCIK 0001893172

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:31 PM ET
Size
6.9 KB